Treatment of myositis ossificans progressiva with a diphosphonate.

The diphosphonate, disodium etidronate (ethane-1-hydroxy-1,1-diphosphonate, 'EHDP'), a compound known to inhibit the crystal growth of hydroxyapatite and to prevent ectopic calcification in experimental animals, has been given to two women with myositis ossificans progressiva. After remova...

Full description

Bibliographic Details
Main Authors: Russell, R, Smith, R, Bishop, M, Price, D
Format: Journal article
Language:English
Published: 1972
_version_ 1826304161199685632
author Russell, R
Smith, R
Bishop, M
Price, D
author_facet Russell, R
Smith, R
Bishop, M
Price, D
author_sort Russell, R
collection OXFORD
description The diphosphonate, disodium etidronate (ethane-1-hydroxy-1,1-diphosphonate, 'EHDP'), a compound known to inhibit the crystal growth of hydroxyapatite and to prevent ectopic calcification in experimental animals, has been given to two women with myositis ossificans progressiva. After removal of ectopic bone during treatment with disodium etidronate there was no X-ray evidence of significant recalcification six months later in one patient, and a year later in the other. On previous occasions removal of ectopic bone had been followed by rapid recurrence at the site of operation. © 1972.
first_indexed 2024-03-07T06:13:35Z
format Journal article
id oxford-uuid:f05c0810-4713-41b6-bada-88373c2ebc4e
institution University of Oxford
language English
last_indexed 2024-03-07T06:13:35Z
publishDate 1972
record_format dspace
spelling oxford-uuid:f05c0810-4713-41b6-bada-88373c2ebc4e2022-03-27T11:47:11ZTreatment of myositis ossificans progressiva with a diphosphonate.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f05c0810-4713-41b6-bada-88373c2ebc4eEnglishSymplectic Elements at Oxford1972Russell, RSmith, RBishop, MPrice, DThe diphosphonate, disodium etidronate (ethane-1-hydroxy-1,1-diphosphonate, 'EHDP'), a compound known to inhibit the crystal growth of hydroxyapatite and to prevent ectopic calcification in experimental animals, has been given to two women with myositis ossificans progressiva. After removal of ectopic bone during treatment with disodium etidronate there was no X-ray evidence of significant recalcification six months later in one patient, and a year later in the other. On previous occasions removal of ectopic bone had been followed by rapid recurrence at the site of operation. © 1972.
spellingShingle Russell, R
Smith, R
Bishop, M
Price, D
Treatment of myositis ossificans progressiva with a diphosphonate.
title Treatment of myositis ossificans progressiva with a diphosphonate.
title_full Treatment of myositis ossificans progressiva with a diphosphonate.
title_fullStr Treatment of myositis ossificans progressiva with a diphosphonate.
title_full_unstemmed Treatment of myositis ossificans progressiva with a diphosphonate.
title_short Treatment of myositis ossificans progressiva with a diphosphonate.
title_sort treatment of myositis ossificans progressiva with a diphosphonate
work_keys_str_mv AT russellr treatmentofmyositisossificansprogressivawithadiphosphonate
AT smithr treatmentofmyositisossificansprogressivawithadiphosphonate
AT bishopm treatmentofmyositisossificansprogressivawithadiphosphonate
AT priced treatmentofmyositisossificansprogressivawithadiphosphonate